Psychopharmacologic Management of Opioid-dependent Women During Pregnancy

Overview

Journal Am J Addict

Specialty Psychiatry

Date 2009 Mar 14

PMID 19283567

Citations 12

Authors

Peter R Martin

Amelia M Arria

Gabriele Fischer

Karol Kaltenbach

Sarah H Heil

Susan M Stine

Mara G Coyle

Peter Selby

Hendree E Jones

Affiliations

Soon will be listed here.

Abstract

Illicit drug use during pregnancy presents complex clinical challenges, including reducing drug use and treating psychiatric disorders. Pharmacologic treatment of psychiatric disorders in a pregnant woman requires an evaluation of the balance between potential clinical benefit and the risk of potential neonatal consequences. This study describes psychiatric symptoms in 111 opioid-dependent pregnant women and their prescribed psychotropic medications. Hypomania, generalized anxiety disorder and depression were the most common disorders for which psychiatric symptoms were endorsed. Over half of women studied were prescribed some form of psychoactive medication during pregnancy. Pharmacologic vs. non-pharmacologic treatment approaches in this patient population are discussed.

Citing Articles

Intact responses to non-drug rewards in long-term opioid maintenance treatment.

Eikemo M, Lobmaier P, Pedersen M, Kunoe N, Matziorinis A, Leknes S Neuropsychopharmacology. 2019; 44(8):1456-1463.

PMID: 30928994 PMC: 6785711. DOI: 10.1038/s41386-019-0377-9.

Neonatal abstinence syndrome.

Coyle M, Brogly S, Ahmed M, Patrick S, Jones H Nat Rev Dis Primers. 2018; 4(1):47.

PMID: 30467370 DOI: 10.1038/s41572-018-0045-0.

Increasing pregnancy-related use of prescribed opioid analgesics.

Epstein R, Bobo W, Martin P, Morrow J, Wang W, Chandrasekhar R Ann Epidemiol. 2013; 23(8):498-503.

PMID: 23889859 PMC: 3888316. DOI: 10.1016/j.annepidem.2013.05.017.

A qualitative study of treatment needs among pregnant and postpartum women with substance use and depression.

Kuo C, Schonbrun Y, Zlotnick C, Bates N, Todorova R, Kao J Subst Use Misuse. 2013; 48(14):1498-508.

PMID: 23819737 PMC: 3795848. DOI: 10.3109/10826084.2013.800116.

Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes.

Benningfield M, Dietrich M, Jones H, Kaltenbach K, Heil S, Stine S Addiction. 2012; 107 Suppl 1:74-82.

PMID: 23106929 PMC: 4315620. DOI: 10.1111/j.1360-0443.2012.04041.x.

References

Jones H, Johnson R, Jasinski D, Milio L . Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Drug Alcohol Depend. 2005; 78(1):33-8. DOI: 10.1016/j.drugalcdep.2004.08.027. View

McCarthy J, Leamon M, Parr M, Anania B . High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol. 2005; 193(3 Pt 1):606-10. DOI: 10.1016/j.ajog.2005.03.072. View

Zeskind P, Stephens L . Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics. 2004; 113(2):368-75. DOI: 10.1542/peds.113.2.368. View

Cott A, Wisner K . Psychiatric disorders during pregnancy. Int Rev Psychiatry. 2004; 15(3):217-30. DOI: 10.1080/0954026031000136848. View

Cox J . Psychiatric morbidity and pregnancy: a controlled study of 263 semi-rural Ugandan women. Br J Psychiatry. 1979; 134:401-5. DOI: 10.1192/bjp.134.4.401. View

Evans J, Heron J, Francomb H, Oke S, Golding J . Cohort study of depressed mood during pregnancy and after childbirth. BMJ. 2001; 323(7307):257-60. PMC: 35345. DOI: 10.1136/bmj.323.7307.257. View

Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M . Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction. 2006; 101(2):275-81. DOI: 10.1111/j.1360-0443.2006.01321.x. View

Moses-Kolko E, Bogen D, Perel J, Bregar A, Uhl K, Levin B . Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005; 293(19):2372-83. DOI: 10.1001/jama.293.19.2372. View

Nunes E, Levin F . Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA. 2004; 291(15):1887-96. DOI: 10.1001/jama.291.15.1887. View

10.

Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1999; 59 Suppl 20:22-33;quiz 34-57. View

11.

Torrens M, Castillo C, San L, Del Moral E, Gonzalez M, de la Torre R . Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program. Drug Alcohol Depend. 1998; 52(3):193-200. DOI: 10.1016/s0376-8716(98)00096-9. View

12.

Fajemirokun-Odudeyi O, Sinha C, Tutty S, Pairaudeau P, Armstrong D, Phillips T . Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol. 2005; 126(2):170-5. DOI: 10.1016/j.ejogrb.2005.08.010. View

13.

Battle C, Zlotnick C, Miller I, Pearlstein T, Howard M . Clinical characteristics of perinatal psychiatric patients: a chart review study. J Nerv Ment Dis. 2006; 194(5):369-77. DOI: 10.1097/01.nmd.0000217833.49686.c0. View

14.

DeRubeis R, Hollon S, Amsterdam J, Shelton R, Young P, Salomon R . Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005; 62(4):409-16. DOI: 10.1001/archpsyc.62.4.409. View

15.

Holcomb Jr W, Stone L, Lustman P, Gavard J, Mostello D . Screening for depression in pregnancy: characteristics of the Beck Depression Inventory. Obstet Gynecol. 1996; 88(6):1021-5. DOI: 10.1016/s0029-7844(96)00329-8. View

16.

Nulman I, Rovet J, Stewart D, Wolpin J, Pace-Asciak P, Shuhaiber S . Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002; 159(11):1889-95. DOI: 10.1176/appi.ajp.159.11.1889. View

17.

Johnson R, Eissenberg T, Stitzer M, Strain E, Liebson I, Bigelow G . Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing. Drug Alcohol Depend. 1995; 40(1):27-35. DOI: 10.1016/0376-8716(95)01189-7. View

18.

Steer R, Scholl T, Hediger M, Fischer R . Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol. 1992; 45(10):1093-9. DOI: 10.1016/0895-4356(92)90149-h. View

19.

Hollon S, Stewart M, Strunk D . Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol. 2005; 57:285-315. DOI: 10.1146/annurev.psych.57.102904.190044. View

20.

Gotlib I, Whiffen V, Mount J, Milne K, Cordy N . Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol. 1989; 57(2):269-74. DOI: 10.1037//0022-006x.57.2.269. View